Alphalyse

21/11/2022

𝗛𝗲𝗹𝗽 𝘂𝘀 𝗺𝗮𝗸𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝗮𝗳𝗲𝗿!

The pharma industry is moving faster than ever; novel vaccines and biotherapeutic treatments are being developed in record time. Documenting the safety and efficacy of life-saving new drugs – so they can be made available to patients as soon as possible – is key to improving healthcare.

👩‍🔬👨‍🔬 Our Impurity Analysis Team is looking for a new colleague with ELISA experience to provide their US and European biopharma clients with ELISA characterization data for drug development & documentation.

You will join a young, dynamic team with strong company values:

✅ We believe that our most important asset is each other

✅ We work actively to ensure everyone thrives, feels part of the team, and enjoys doing meaningful work

✅ Our ambition is to inspire innovation, provide resources for honing and developing skills, and facilitate personal and professional growth

✅ Creating a healthy work environment is one of our core values. We offer opportunities for working from home, flexible working hours, and recreational activities, and we actively seek to integrate the UN Sustainability Goals for health, education, innovation, growth, and equality into our company strategy

Would you like to help us perform high-quality protein analysis services for clients and contribute to developing safe and life-saving new medicines and vaccines?

Check out the details on our website or share this post with someone who may be interested >>

We are looking for a new colleague with a PhD or MSc in Biomedicine/Biochemistry/ Pharmaceutical science – or similar

07/11/2022

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮𝗻 𝗲𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗰𝗮𝗿𝗲𝗲𝗿 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆?

We’re looking for you!

We seek a new colleague with experience in protein chemistry/biomedicine/pharmaceutical science or similar for our characterization team.

We are a young, dynamic team with strong company values:

• We believe that our most important asset is each other
• We work actively to create an employee culture where people thrive, feel part of the team, and enjoy doing meaningful work
• Our ambition is to inspire innovation, provide resources for honing and developing skills, and facilitate personal and professional growth
• Just as our mission is to contribute to better public health through development of safer medicines and vaccines, we also focus on creating a healthy work environment through opportunities for WFH, flexible working hours, recreational activities, and actively integrating the UN Sustainability Goals for health, education, innovation, growth, and equality into our company strategy

Would you like to join our Alphalyse team, perform high-quality protein analysis services for clients all over Europe and USA, and contribute to the development of safe and life-saving new medicines and vaccines?

Check out the details on our website or share this post with someone who may be interested: https://www.alphalyse.com/about-us/careers/lc-ms-protein-scientist-characterization-team

05/11/2022

In this webinar, Dr. Thomas Kofoed will discuss the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities.

05/11/2022

𝗣𝗥𝗘𝗦𝗦 𝗥𝗘𝗟𝗘𝗔𝗦𝗘: 𝗔𝗹𝗽𝗵𝗮𝗹𝘆𝘀𝗲 𝗵𝗮𝘀 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗲𝗱 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗳𝗶𝗿𝘀𝘁 𝗠𝗦-𝗯𝗮𝘀𝗲𝗱 𝗛𝗖𝗣 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝘂𝗻𝗱𝗲𝗿 𝗚𝗠𝗣 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗿𝗲𝗹𝗲𝗮𝘀𝗲 𝘁𝗲𝘀𝘁 𝗼𝗳 𝗕𝗮𝘃𝗮𝗿𝗶𝗮𝗻 𝗡𝗼𝗿𝗱𝗶𝗰 𝗔/𝗦 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗯𝗼𝗼𝘀𝘁𝗲𝗿 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲.

We proudly announce the successful performance of the world’s first GMP-certified mass spectrometry (MS)-based Host Cell Protein (HCP) analysis for product release testing for Phase 3 clinical trial.

The unique LC-MS-based HCP analysis developed by Alphalyse is significantly faster than traditional methods for product impurity documentation and has the potential to reduce the time required to document new vaccines, from the current industry standard of 12-18 months to as little as 4 months, while being as safe or safer than older methods.

This makes the Alphalyse method particularly useful for developing vaccines during a global pandemic when the time to create a process-specific ELISA is limited.


Read the full press release on our website: https://lnkd.in/eNJq5TPB

Alphalyse and Bavarian Nordic A/S significantly shorten the time necessary to document HCP impurities in COVID-19 vaccine candidate for Phase 3 clinical trial – through the world’s first MS-based HCP analysis under GMP conditions ODENSE, Denmark, November 3, 2022 –Alphalyse has performed the w...

07/09/2022

Friday, we celebrated our 20 years in business 🎉🥳
Around 150 guests and employees made this the most fantastic day - Thank you for making it memorable!

04/04/2022

Vi søger lige nu to GMP laboranter til at indgå i vores team der analyserer lægemidler for vores kunder: http://ow.ly/lavo50IzpT0

→ Tip meget gerne en ven at tagge dem.

20/10/2021

When you use generic ELISA kits, one of the validation experiments is to show dilutional linearity.

But what if this experiment fails? 🙈

This video takes you into the machine room of one of our clients, who had this exact problem.

12/10/2021

The close proximity of Syddansk Universitet - University of Southern Denmark (SDU) to the Alphalyse Headquarters gives us unique access to very well-educated and specialized employees. This month, we are thus excited to welcome two SDU alumnae, Freja and Sindhu, to our team 🤩

👩‍🔬 Sai Sindhu Thangaraj just finished her PhD Thesis in Cardiovascular Inflammation. Sindhu’s industrial and academic background provided her with key competencies such as

• expression and purification of mAbs and recombinant proteins,
• vaccine development and vaccinology,
• immunologic techniques,
• and ELISA development.

👩‍🔬 Freja Andersen comes from a position as Production QA Specialist in a medicinal cannabis company. She is specialized in
• analysis and production according to GMP standards,
• method validation,
• and GMP documentation.

Furthermore, Freja has extensive experience with immunological techniques, ELISA, and the expression and purification of recombinant proteins.

👉Sindhu and Freja will be principal investigators on many of our host cell protein analysis projects and look forward to working with our many international clients.

Welcome to the team; we are very excited to have you on board! 👏

05/10/2021

Our two founders, Thomas Kofoed and Ejvind Mortz have been nominated by PWC as 'Owner Managers of the Year'

Mange mennesker brænder for at gøre en positiv forskel for andre. Thomas Kofoed og Ejvind Mørtz driver sammen Alphalyse, der udvikler, sælger og udfører...

27/09/2021

"The Food and Drug Administration (FDA) is increasingly requesting cell and gene therapy developers to measure the characteristics of their complex products.

However, many CMC managers cannot find a suitable commercial HCP ELISA. And the short project timelines do not allow for the development of a process-specific ELISA. Thus, many look for orthogonal HCP methods.

Join Ejvind Mortz on October 5 to discover why the industry now turns to LC-MS analysis to characterize and monitor process-related impurities in cell and gene therapies.

Learn more → " https://www.alphalyse.com/customer-support/webinars/monitoring-impurities-gtp/

20/05/2021

WE'RE HIRING!… Are you, or do you know someone, who is interested in a career in a fast-growing contract research laboratory?

Right now we seek two service-minded and dedicated analytical protein scientists for our Headquarters in Odense, Denmark to join our team who performs impurity analysis of biologicals for clients.

We offer an exciting, challenging, and fun work environment in new premises - close to SDU.

Find out more right here: http://ow.ly/eM5z50EEcUE

23/04/2021

Great article on understanding HCP profiles and integrating effective removal strategies in development of new biological drugs.

March 2021 - Featured Report